Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08FRG
|
||||
| Former ID |
DIB005859
|
||||
| Drug Name |
EphA2-targeting BiTE molecules
|
||||
| Synonyms |
BscEphA2xCD3; MEDI-544; Anticancer BiTE, Micromet/MedImmune; EphA2-targeting BiTE molecules, Micromet; Bispecific T-cell engager (cancer), MedImmune/Micromet
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543506] | ||
| Company |
Micromet AG
|
||||
| Target and Pathway | |||||
| Target(s) | Ephrin type-A receptor 2 | Target Info | Modulator | [543506] | |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| WikiPathways | NRF2 pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.